Clinical trial · Observational
Sexual Functioning in Endometrial Cancer
Sexual Functioning in Endometrial Cancer Survivors
NCT00543192CI-TRIAL-00041749completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is estimate how sexual function in endometrial cancer survivors varies with severity of disease.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometrial Cancer | Malignant Endometrial Neoplasm | CURATED_BROADER | 0.80 |
| Sexual Function | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Female Sexual Function Index (FSFI).
- timeFrame
- at time of enrollment
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 19 Years
Show eligibility criteria text
Inclusion Criteria: * History of Stage I-IIIA endometrial adenocarcinoma of any grade * 1-5 years out from primary surgical treatment * Adjuvant therapy may only have consisted of radiation or hormonal therapy * No evidence of disease Exclusion Criteria: * Previous treatment for other malignancies * Did not undergo surgery for primary treatment of endometrial cancer * Inability to read, write and speak fluent English * Major cognitive impairment affecting ability to provide consent
References
Publications (1)
- RESULTOnujiogu N, Johnson T, Seo S, Mijal K, Rash J, Seaborne L, Rose S, Kushner DM. Survivors of endometrial cancer: who is at risk for sexual dysfunction? Gynecol Oncol. 2011 Nov;123(2):356-9. doi: 10.1016/j.ygyno.2011.07.035. PMID 21855974